SMi Group reports: the key conference sessions during the 6th Annual HPAPi Conference are released SMi’s 6th Annual Highly Potent APi Conference will also explore the ADC industry, legal aspects, environmental policy, and how to effectively establish […]
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has provided a positive opinion recommending the conditional marketing authorization (CMA) of Pfizer’s oral therapy for Covid-19, Paxlovid. Paxlovid is intended to […]
Cocrystal Pharma has announced the selection of two investigational antiviral drug candidates, CDI-988 and CDI-873, to further develop them as oral therapies to treat Covid-19. The new broad-spectrum oral candidates act on a conserved area […]
Screening for premalignant precursor conditions could serve as an important step in the early detection and treatment of multiple myeloma. However, more insights are needed to determine the optimal criteria for screening programs, experts say, […]
Zydus has commenced the delivery of the first consignment of its Covid-19 deoxyribonucleic acid (DNA) Plasmid vaccine, ZyCoV-D, to the Government of India. On administration, the vaccine generates the SARS-CoV-2 viral spike protein and induces […]